Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Nosopharm Signs Partnership with INRAE and University of Montpellier to Develop New Anti-infectives
Nosopharm, specialized in exploring unconventional sources of antibiotics to discover new drugs to fight antimicrobial […]
Now Available Over the Counter, LASTACAFT ® Provides Eye Allergy Itch Relief in Minutes that Lasts Through 16 Hours
Allergan, an AbbVie (NYSE: ABBV) company, today announced that LASTACAFT ® (alcaftadine ophthalmic solution 0.25%) is […]
Life-extending Injection for Blood Cancer Available on the NHS
A life-extending injection for a fatal form of blood cancer will be available to around […]
New Data for Roche’s Evrysdi (risdiplam) Demonstrate Long-term Efficacy and Safety in a Broad Population of People with Spinal Muscular Atrophy (SMA)
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new data for Evrysdi® (risdiplam) in spinal muscular atrophy […]
Curebase and Blue Note Therapeutics Collaborate on Home-based Clinical Trial of Prescription Digital Therapeutics to Help People with Cancer Manage their Health
Curebase, a company committed to democratizing access to clinical studies, and Blue Note Therapeutics, a prescription […]
Envirotainer and Swiss WorldCargo Complete the First Commercial Shipment Using the New Releye® RAP
Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, […]
Zeta Surgical Raises $5.2M in Seed Financing to Enhance Surgical Navigation with Robotics and Mixed Reality
Zeta Surgical, a surgical robotics and mixed reality company, announced today the close of a $5.2M financing […]
Promega Corporation and FUJIFILM Cellular Dynamics Announce Strategic Collaboration to Advance Novel Assay Development
Promega Corporation (Promega), a leader in providing innovative solutions and technical support to the life sciences industry, […]
AbbVie and Gedeon Richter Announce Collaboration in Neuropsychiatric Diseases
AbbVie (NYSE: ABBV) and Gedeon Richter Plc. (‘Richter’) today announced a new co-development and license […]
Orexo Appoints Fredrik Järrsten as New CFO
Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), announces today that the company has appointed Fredrik Järrsten as […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more